Company / CapEx per Share
NOVAVAX INC CapEx per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.72
FY2022
5-year range
$0.72 / $0.81
FY2018-FY2022
Trend
-11.3%
vs FY2021
Sector context
#16 of 192
Health Care
What the data says
Among 192 Health Care companies, NOVAVAX INC is in the top 8% for capex per share. CapEx per Share has fluctuated over the past 7 years, ranging from $0.03 in FY2016 to $1.69 in FY2020.
Based on SEC 10-K filings.
0.72 in FY2022 with a 5-year CAGR of +60.5%. Top quartile in the Health Care sector.
Declined from $1.69 to $0.72 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +48.8%
- 5-Year CAGR
- +60.5%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 192This company $0.72 Sector average $2.46
▼
-70.8% below sector average
Key checks
Key Insights
- In FY2022, capex per share decreased 11.3% year-over-year.
- Ranks #16 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.72 | -11.3% |
| FY2021 | $0.81 | -52.0% |
| FY2020 | $1.69 | +674.7% |
| FY2019 | $0.22 | +287.0% |
| FY2018 | $0.06 | -16.4% |
| FY2017 | $0.07 | +150.2% |
| FY2016 | $0.03 | +11.1% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026